glutathione and parkinsons disease S-transferase: A keystone in Parkinson's pathogenesis therapy NAD IV Therapy and IV

For an analysis of the risk associated with the deletion polymorphism for GSTT1 , it was found that the null genotype (p = 0.0004) is related to an increased predisposition for T2DM (Table 2), conferring a 3.2-fold increased risk of developing the disease relative to the present genotype

The following classification reflects current evidence and clinical experience, ranging from agents that should be categorically avoided to those that may actually help

The induction of an inflammatory milieu and BBB impairment have been uncoupled by inhibition of nitric oxide synthesis in the cuprizone model [29] or by targeted overexpression of claudin-1 in EAE [44] that both support BBB tightness but presumably do not (directly) affect expression of pro-inflammatory molecules

Pineapple, rich in vitamin C and bromelain, helps exfoliate and brighten the skin

Invest in your health and feel the difference

The human stomach in health and disease: Infection strategies by Helicobacter pylori